CCM
LJPC

Consonance Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Consonance Capital Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,079,311
Closed -$66.9M – 30
2017
Q4 		$66.9M Buy
2,079,311
+76,792
+4% +$2.51M 6.04% 9
2017
Q3 		$69.6M Sell
2,002,519
-10,000
-0.5% -$322K 7.7% 7
2017
Q2 		$59.9M Buy
2,012,519
+591,777
+42% +$17M 7.06% 8
2017
Q1 		$42.4M Buy
+1,420,742
New +$36.3M 4.44% 12

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Consonance Capital Management's LJPC Position: Q1 2018 in Review

Consonance Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2018, closing a stake of 2,079,311 shares — an estimated $66.9M sold.

Consonance Capital Management first reported a position in LJPC in Q1 2017 and held it in 4 quarters. The position peaked at $69.6M in Q3 2017. 100 funds tracked by Wall St. Rank hold LJPC as of Q1 2018.

  • Consonance Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q1 2018 after selling out during the quarter.
  • Consonance Capital Management sold 2,079,311 La Jolla Pharmaceutical Company shares in Q1 2018, an estimated $66.9M.
  • Consonance Capital Management first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 4 quarters.
  • Consonance Capital Management's La Jolla Pharmaceutical Company position peaked at $69.6M in Q3 2017.
  • 100 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2018.

Based on Consonance Capital Management's 13F filing for Q1 2018, filed 15 May 2018.